¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"electrolyte deficiency syndrome"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • Wolff-Parkinson-White syndrome
    ¿ùÇÁÆÄŲ½¼È­ÀÌÆ® ÁõÈıº
  • Wyburn-Mason syndrome
    À§¹ø¸Å½¼ ÁõÈıº
  • X-linked lymphoproliferative syndrome
    ¼º¿°»öü ¿¬°ü ¸²ÇÁÁõ½Ä ÁõÈıº
  • XXY syndrome
    XXYÁõÈıº.
  • XXYY syndrome
    XXYYÁõÈıº.
  • Zieves syndrome
    ÁöºêÁõÈıº
  • Zollinger-Ellison syndrome
    Á¹¸µ°Å ¿¤¸®¼Õ ÁõÈıº
  • Zollinger-Ellison syndrome
    Á¹¸°°Å-¿¤¸®½¼ ÁõÈıº
  • Zollinger-Ellison syndrome
    Á¹¸µ°Å-¿¤¸®½¼ ÁõÈıº
  • absent pulmonary valve syndrome
    Æóµ¿¸ÆÆÇ°á¿©Áõ.
  • absent pulmonary valve syndrome
    Æóµ¿¸ÆÆÇ°á¿©Áõ.
  • absent testes syndrome
    °íȯ°á¿©ÁõÈıº
  • abstinence syndrome
    ±Ý´ÜÁõÈıº(Ð×Ó¨ñøý¦ÏØ).
  • acid aspiration syndrome
    À§»ê ÈíÀÔ ÁõÈıº
  • acquired immunodeficiency syndrome
    ÈÄõ¼º¸é¿ª°áÇÌÁõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • basal cell nevus syndrome
    ±âÀú¼¼Æ÷¸ð¹ÝÁõÈıº(¡­Ù½Úèñøý¦ÏØ).
  • basal cell nevus syndrome
    ±âÀú¼¼Æ÷¸ð¹ÝÁõÈıº(¡­Ù½Úèñøý¦ÏØ)
  • basilar syndrome
    ³úÀúµ¿¸ÆÁõÈıº(¡­ÔÑØæñøý¦ÏØ).
  • battered child syndrome
    ¸Å¸Â´Â¾Æµ¿ ÁõÈıº
  • battered child syndrome
    ¸Å¸Â´Â¾ÆÀÌÁõÈıº
  • beckwith-wiedemann syndrome
    º£Å©À§µå-À§µå¸¸ ÁõÈıº(¡­ñøý¦ÏØ)
  • bernard-soulier syndrome
    ¹ö³ªµå-½¶¸®¾î ÁõÈıº(¡­ñøý¦ÏØ)
  • big heart syndrome
    °Å½ÉÁõÈıº(ËÝãýñøý¦ÏØ)
  • big heart syndrome
    °Å½ÉÁõÈıº(ËÝãýñøý¦ÏØ).
  • big spleen syndrome
    °Å´ëºñÀåÁõÈıº(ËÝÓÞÞ¡íôñøý¦ÏØ).
  • black cardiac syndrome
    Èæ½ÉÀåÁõÈıº(ýÙãýòÅñøý¦ÏØ).
  • blast syndrome
    Æø¹ßÁõÈıº(¡­ñøý¦ÏØ).
  • blind loop syndrome
    ¸Í°èÁ¦ÁõÈıº (¡­ñøý¦ÏØ).
  • blind loop syndrome
    ¸ÍÀå°ü ÁõÈıº(Øîíóηñøý¦ÏØ)
  • blind spot syndrome
    ¸ÍÁ¡ÁõÈıº(ØîïÇñøý¦ÏØ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
IGHD immunoglobin delta heavy chain; isolated growth hormone deficiency
IHGD isolateral human growth deficiency
ILD interstitial lung disease; intraoperative localization device; ischemic leg disease; ischemic limb d...
ITSHD isolated thyroid-stimulating hormone deficiency
LAD lactic acid dehydrogenase; left anterior descending [artery]; left axis deviation; leukocyte adhesio...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
CS Cocayne syndrome
CLS Coffin-Lowry syndrome
CAIS Complete Androgen Insensitivity Syndrome
CRPS Complex Regional Pain Syndrome
CRPS-I Complex Regional Pain Syndrome Type I
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • lobotomy syndrome
    ³ú¿± Àý´Ü¼ú ÁõÈıº
  • lock pin ¼±´ÜÀº taperÇÏ°í µÎºÎ´Â ±¸»óÀ¸·Î µÇ¾î ÀÖ´Â Ä¡³»°ñ³» ¸Å½ÄüÀÇ ÀÏÁ¾.

    locked-in syndrome

    Æó¼â ÁõÈıº
  • long tract syndrome
    Àå°æ·Î ÁõÈıº
  • low output syndrome
    Àú ¹ÚÃâ·® ÁõÈıº
  • low salt syndrome
    Àú¿° ÁõÈıº
  • lower nephron syndrome
    ÇϺΠ³×ÇÁ·Ð ÁõÈıº
  • lupus erythematosus like syndrome
    È«¹Ý¼º ·çǪ½º¾ç ÁõÈıº
  • lupus-like syndrome
    ³¶Ã¢ ¾ç»óÀÇ ÁõÈıº
  • luxury perfusion syndrome
    ȣȭ °ü·ù ÁõÈıº
  • Lyell syndrome
    Lyell ÁõÈıº
  • malabsorption syndrome
    Èí¼öÀå¾Ö ÁõÈıº
    Á¤°ü¿¡¼­ÀÇ ¿µ¾ç¹° Èí¼öÀÇ Àå¾Ö¸¦ °¡Á®¿À´Â ÁúȯÀ» ÃѰýÇÏ´Â ¸íĪ. ¼³»ç, üÁß °¨¼Ò, ¿µ¾ç½ÇÁ¶¸¦ °¡Á®¿À´Â ¿øÀÎÀÌ µÇ´Â ÁúȯÀº Àå°ü ¼ö¼ú µÚ, Àå Áúȯ, ÃéÀå Áúȯ, °£´ãµµ Áúȯ, ¸²ÇÁÁ¾, ½ÉºÎÀü, ½É³¶¿°, ¾Æ´Ò·ÎÀ̵å½Ã½º, ¥â-Áö¹æ ´Ü¹é °á¼ÕÁõ, ½ºÇª·ç¿ì
  • maladaptation syndrome
    ÀûÀÀ Àå¾Ö ÁõÈıº
  • male Turners syndrome
    ³²¼º ÅÍ³Ê ÁõÈıº
  • malignant hyperthermia syndrome
    ¾Ç¼º °í¿­ ÁõÈıº
  • Mallory-Weiss syndrome
    ¸»·Î¸®-¹ÙÀ̽º ÁõÈıº, ¸È·Î¸®¿ÍÀ̽º ÁõÈıº
    1. ±¸Åä¿¡ ÀÇÇØ ½ÄµµÀ§ °áÇÕºÎÀÇ Á¡¸· ¿­»óÀ» ¸»Çϴµ¥, ¹ß»ý ±âÀüÀ¸·Î´Â ½ÉÇÑ ±¸Åä ½Ã °©ÀÛ½º·± º¹¾ÐÀÇ »ó½ÂÀÌ ¿øÀÎÀÌ µÇ¸ç ȯÀÚ´Â ÁßÁõ ¾ËÄÚ¿Ã Áßµ¶°ú °ü·ÃµÈ ¸¸¼º ±¸ÅäÁõÀÌ ÀÖ´Ù. º´¸® ¼Ò°ßÀ¸·Î´Â À§Àå »óºÎ°¡ º¸Åë ħ¹üµÇ¸ç À§ ºÐ¹®ÀÇ ´ë¸¸ÀÌ °¡Àå ÈçÈ÷ ħ¹üµÈ´Ù. ÅëÁõÀº ¾øÀÌ À§Àå ÃâÇ÷ÀÌ »ý±ä´Ù. ÃâÇ÷ Áõ»óÀº Ç÷º¯º¸´Ù´Â ÅäÇ÷ÀÇ ÇüÅ·Πº¸Åë ³ªÅ¸³­´Ù. Áø´ÜÀº ³»½Ã°æÀ¸·Î Á¡¸· ¿­»óÀ» Áõ¸íÇÏ¿© È®ÁøÇϸç Ä¡·á´Â À§ Àå°ü ÃâÇ÷¿¡ ´ëÇÑ ´ëÁõÀû ¿ä¹ýÀ» ¸ÕÀú ½ÃÀÛÇÏ¿© ¸¸ÀÏ ÃâÇ÷ÀÌ Áö¼ÓµÇ¸é Áï½Ã ¼ö¼úÀ» ½ÃÇàÇÑ´Ù. ¼ö¼ú ÈÄ ¿¹ÈÄ´Â ÁÁ´Ù. 2. ½ÉÇÑ ±¸Åä¿Í ±¸¿ªÀÌ ¸î ½Ã°£ ¶Ç´Â ¸çÄ¥°£ Áö¼ÓµÈ ÈÄ¿¡ ÅäÇ÷, ÇÏÇ÷À» ÀÏÀ¸Å°´Â Áúȯ. 1929³â ¹Ì±¹ º´¸®ÇÐÀÚ G.K. ¸È·¯¸®¿Í ³»°úÀÇ»ç S. ¿ÍÀ̽º
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
burning foot syndrome <syndrome> A disorder observed in prisoners-of-war in World War II, now believed to be due to a pantothenate deficiency.
(05 Mar 2000)
burning mouth syndrome <syndrome> A group of painful oral symptoms associated with a burning or similar sensation. There is usually a significant organic component with a degree of functional overlay; it is not limited to the psychophysiologic group of disorders.
(12 Dec 1998)
burning vulva syndrome <syndrome> Persistent vulvodynia in which a physical cause has not been identified.
(05 Mar 2000)
Buschke-Ollendorf syndrome Osteopoikilosis with skin lesions, most commonly small elastic fibrous nodules on the posterior aspects of the thighs and buttocks; irregular autosomal dominant inheritance.
Synonym: Buschke-Ollendorf syndrome.
Origin: osteo-+ G. Derma, skin, + poikilos, dappled, + -osis, condition
(05 Mar 2000)
Caffey-Kempe syndrome <radiology> Multiple assymetrical fractures, separation of distal epiphyses, irregularity and fragmentation of metaphyses, bucket-handle fracture, corner fracture of elbow, knee, ankle (sudden twisting motion), isolated spiral fracture, extensive periosteal reaction (subperiosteal haemorrhage), exuberant callus formation, cortical hyperostosis extending to epiphyseal plate, avulsion fracture at ligamentous insertion, subdural haematoma (most common), brain atrophy (up to 100%), infarction (50%), subdural hygroma, encephalomalacia, porencephaly
(12 Dec 1998)
Caffey-Silverman syndrome Neonatal subperiosteal bone formation over many bones, especially the mandible and clavicles and the shafts of long bones; it follows fever, usually appearing before 6 months of age and disappearing during childhood.
Synonym: Caffey's disease, Caffey's syndrome, Caffey-Silverman syndrome.
(05 Mar 2000)
Caffey's syndrome Neonatal subperiosteal bone formation over many bones, especially the mandible and clavicles and the shafts of long bones; it follows fever, usually appearing before 6 months of age and disappearing during childhood.
Synonym: Caffey's disease, Caffey's syndrome, Caffey-Silverman syndrome.
(05 Mar 2000)
camptomelic syndrome <syndrome> Also associated with flat facies, short vertebrae, hypoplastic scapula, and bowed tibia.
Synonym: osteochondrodysplasia.
(05 Mar 2000)
cantrell syndrome <radiology> Herniation of gut into pericardial sac, common anterior communication in diaphragm and pericardium, associated with congenital defects of sternum, heart, mesentery, anterior abdominal wall, must be excluded in presence of omphalocele, ** diaphragmatic hernia
(12 Dec 1998)
capgras syndrome <syndrome> A psychotic disorder characterised by the patient's conviction that certain important or familiar persons in his environment are not real but are "doubles" of themselves or imposters.
(12 Dec 1998)
Capgras' syndrome <syndrome> The delusional belief that a person (or persons) close to the schizophrenic patient has been substituted for by one or more impostors; may have an organic aetiology.
Synonym: Capgras' phenomenon, illusion of doubles.
(05 Mar 2000)
capillary leak syndrome <syndrome> Extravasation of plasma fluid and proteins into the extravascular space, resulting in sometimes fatal hypotension and reduced oxygen perfusion. Clinical capillary leak syndrome is observed in patients who demonstrate a state of generalised leaky capillaries following shock syndromes, low-flow states, ischemia-reperfusion injuries, toxaemias, or poisoning. It can lead to generalised oedema and multiple organ failure., reperfusion injuries and clinical capillary leak syndrome.
(12 Dec 1998)
caplan's syndrome <syndrome> Pneumoconiosis associated with rheumatoid arthritis.
(12 Dec 1998)
caplan syndrome <radiology> Combination of: necrobiotic rheumatoid lung nodules, coal worker's pneumoconiosis Findings: round, peripheral nodules (0.5 - 5.0 cm), with or without cavitation, nodules associated with subcutaneous rheumatoid nodules
(12 Dec 1998)
carbohydrate-deficient glycoprotein syndrome <syndrome> An inborn error of carbohydrate metabolism manifesting as a genetic multisystem disorder of autosomal recessive inheritance. A predominant feature is severe central and peripheral nervous system involvement resulting in psychomotor retardation, seizures, cerebellar ataxia, and other symptoms which include growth retardation, retinitis pigmentosa, hypothyroidism, and fatty liver. The notable biochemical feature is the deficiency of a large number of blood glycoproteins and decreased activities of various blood coagulation factors.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á